Drawing for SLTX

USPTO serial 88197578

SLTX

Reviewed by CopyMark Law Group

Reg. 6201037Status 700Renewal
Filing date
Status date
Registration date
Nov 17, 2020
Examiner
MURRAY, GEORGE WILLIAM
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SLTX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John R. Rudolph

John R. Rudolph Eli Lilly and CompanyLilly Corporate Centerwww.lilly.comIndianapolis, IN 46285

Goods and services

ClassDescriptionStatusFirst use
001Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research useACTIVESep 17, 2020
005Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cellsACTIVEJul 28, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 18, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 18, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 18, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 18, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 17, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 14, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 13, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 7, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 7, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 23, 2020IUAFUSE AMENDMENT FILED—
Sep 23, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 19, 2020EX2GSOU EXTENSION 2 GRANTED—
May 19, 2020EXT2SOU EXTENSION 2 FILED—
May 19, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 6, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 4, 2019EXT1SOU EXTENSION 1 FILED—
Nov 4, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 25, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 20, 2019DOCKASSIGNED TO EXAMINER—
Dec 4, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance